Synergistic cooperation between c-Myc and Bcl-2 in lymph node progression of T1 human breast carcinomas

Breast Cancer Research and Treatment

Volumn 54, Issue 1, 1999, Pages 39-45

  Sierra, Angels ^a,c   Castellsague, Xavier ^b   Escobedo, Agustin ^c   Moreno, Abelardo ^d   Drudis, Teresa ^e   Fabra, Angels ^a  

^a Institut de Recerca Oncologica   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c HOSPITAL DURAN I REYNALS   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Apoptosis; Bcl 2; Breast cancer; c Myc; Metastasis

Indexed keywords

MYC PROTEIN; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL DIVISION; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LOGISTIC MODELS; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 0032896630     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006120006471     Document Type: Article

References (29)

1. 1. Evan GI, Brown L, Whyte M, Harrington E: Apoptosis and the cell cycle. Curr Opin Cell Biol 7: 825-834, 1995
2. 2. Packham G, Porter CW, Cleveland JL: c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene 13: 461-469, 1996
3. 3. Watson PH, Safneck JR, Le K, Duhik D, Shiu RPC: Relationship of c-Myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. J Natl Cancer Inst 85: 902-907, 1993
4. 4. Nass SJ, Dickson RB: Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Res Treat 44: 1-22, 1997
5. 5. Thompson EB: The many roles of c-Myc in apoptosis. Annu Rev Physiol 60: 575-600, 1998
6. 6. Fanidi A, Harrington EA, Evan GI: Cooperative interaction between c-Myc and Bel-2 proto-oncogenes. Nature 359: 554-556, 1992
7. 7. Korsmeyer SJ: Regulators of cell death. Trends in Genet 11: 101-105, 1995
8. 8. Hockenbery DM: Bcl-2 in cancer, development and apoptosis. J Cell Sci 18: 51-55, 1994
9. 9. Strasser A, Harris AW, Bath ML, Cory S: Novel primitive lymphoid tumours induced in transgenic mice by cooperation between Myc and Bcl-2. Nature 348: 331-333, 1990
10. 10. Marin MC, Hsu B, Stephens LC, Brisbay S, McDonnell TJ: The functional basis of c-Myc and Bcl-2 complementation during multistep lymphomagenesis in viva. Exp Cell Res 217: 240-247, 1995
11. 11. Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Di Fronzo G, Rilke F, Veronesi U: The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph-node-negative breast cancer patients. J Nat Cancer Inst 86: 499-504, 1994
12. 12. Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL: Bcl-2 in normal human breast and carcinoma: association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 69: 135-139, 1994
13. 13. Sierra A, Lloveras B, Castellsagué X, Moreno L, Garcia-Ramirez M, Fabra A: Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma. Int J Cancer 60: 54-60, 1995
14. 14. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B: Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55: 237-241, 1995
15. 1 breast cancer. Clin Cancer Res 2: 1887-1894, 1996
16. 16. Kang Y, Cortina R, Perry RR: Role of c-Myc in tamoxifen-induced apoptosis in estrogen-independent breast cancer cells. J Natl Cancer Inst 88: 279-284, 1996
17. 17. Alarcon RM, Rupnow BA, Graeber TG, Knox SJ, Giaccia AJ: Modulation of c-Myc activity and apoptosis in vivo. Cancer Res 56: 4315-4319, 1996
18. 18. Hundley JE, Koester SK, Troyer DA, Hilsenbeck SG, Barrington RE, Windle JJ: Differential regulation of cell cycle characteristics and apoptosis in MMTV-Myc and MMTV-ras mouse mammary tumors. Cancer Res 57: 600-603, 1997
19. 19. Gibson AW, Cheng T, Johnston RN: Apoptosis induced by c-Myc overexpression is dependent on growth conditions. Exp Cell Res 218: 351-358, 1995
20. 20. Mooy CM, Luyten GPM, de Jong PTVM, Luider TM, Stijnen T, van de Ham F, van Vroonhoven CCJ, Bosman FT: Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma. Am J Pathol 147: 1097-1104, 1995
21. 21. Siitonen SM, Kallioniemi O-P, Isola JJ: Proliferating cell nuclear antigen immunohistochemistry using monoclonal 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer. Am J Pathol 142: 1081-1089, 1993
22. 22. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992
23. 23. Breslow NE, Day NE: Statistical methods in cancer research: Volume 1 - The analysis of case-control studies, (IARC Scientific Publications No. 32), Lyon, International Agency for Research on Cancer, 1980
24. 24. Baker RJ, Nelder JA: The GLIM system, Release 3. Generalized linear interactive modelling. Numerical Algorithms Group, Oxford, 1978
25. 1 ductal breast carcinomas. Int J Cancer 79: 103-110, 1998
26. 26. Lee YJ, Galoforo SS, Berns CM, Tong WP, Kim HRC, Corry PM: Glucose deprivation-induced cytotoxicity in drug resistant breast carcinoma MCF-7/ADR cells: role of c-Myc and Bcl-2 in apoptotic cell death. J Cell Sci 110: 681-686, 1997
27. 27. Bouehard C, Staller P, Eilers M: Control of cell proliferation by Myc. Trends Cell Biol 8: 202-206, 1998
28. 28. Brouillet JP, Theillet C, Maudelonde T, Defrenne A, Simony-Lafontaine J, Sertour J, Pujol H, Jeanteur P, Rochefort H: Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-Myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness. Eur J Cancer 26: 437-441, 1990
29. 29. Bover L, Barrio M, Bravo AI, Slavutsky I, Larripa I, Bolondi A, Ayala M, Mordoh J: The human breast cancer cell line IIB-BR-G has amplified c-Myc and c-Fos oncogenes in vitro and is spontaneously metastatic in vivo. Cell Mol Biol 44: 493-504, 1998